{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:20:06Z","timestamp":1792545606984,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,5]],"date-time":"2018-07-05T00:00:00Z","timestamp":1530748800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13058-018-0993-z","type":"journal-article","created":{"date-parts":[[2018,7,5]],"date-time":"2018-07-05T08:47:59Z","timestamp":1530780479000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Evaluation of \u03b1-tubulin, detyrosinated \u03b1-tubulin, and vimentin in CTCs: identification of the interaction between CTCs and blood cells through cytoskeletal elements"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9825-3871","authenticated-orcid":false,"given":"G.","family":"Kallergi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Aggouraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Zacharopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Stournaras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Georgoulias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. S.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,5]]},"reference":[{"issue":"22","key":"993_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1462399401003520","volume":"3","author":"S Braun","year":"2001","unstructured":"Braun S, Harbeck N. Molecular markers of metastasis in breast cancer: current understanding and prospects for novel diagnosis and prevention. Expert Rev Mol Med. 2001;3(22):1\u201314.","journal-title":"Expert Rev Mol Med"},{"issue":"17","key":"993_CR2","first-page":"6326","volume":"9","author":"K Pantel","year":"2003","unstructured":"Pantel K, Muller V, Auer M, Nusser N, Harbeck N, Braun S. Detection and clinical implications of early systemic tumor cell dissemination in breast cancer. Clin Cancer Res. 2003;9(17):6326\u201334.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"993_CR3","doi-asserted-by":"publisher","first-page":"R59","DOI":"10.1186\/bcr2896","volume":"13","author":"G Kallergi","year":"2011","unstructured":"Kallergi G, Papadaki MA, Politaki E, Mavroudis D, Georgoulias V, Agelaki S. Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients. Breast Cancer Res. 2011;13(3):R59.","journal-title":"Breast Cancer Res"},{"key":"993_CR4","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1186\/1471-2407-14-651","volume":"14","author":"MA Papadaki","year":"2014","unstructured":"Papadaki MA, Kallergi G, Zafeiriou Z, Manouras L, Theodoropoulos PA, Mavroudis D, Georgoulias V, Agelaki S. Co-expression of putative stemness and epithelial-to-mesenchymal transition markers on single circulating tumour cells from patients with early and metastatic breast cancer. BMC Cancer. 2014;14:651.","journal-title":"BMC Cancer"},{"issue":"4","key":"993_CR5","doi-asserted-by":"publisher","first-page":"R46","DOI":"10.1186\/bcr2333","volume":"11","author":"B Aktas","year":"2009","unstructured":"Aktas B, Tewes M, Fehm T, Hauch S, Kimmig R, Kasimir-Bauer S. Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients. Breast Cancer Res. 2009;11(4):R46.","journal-title":"Breast Cancer Res"},{"issue":"24","key":"993_CR6","doi-asserted-by":"publisher","first-page":"8185","DOI":"10.1158\/1078-0432.CCR-03-0094","volume":"10","author":"V Bozionellou","year":"2004","unstructured":"Bozionellou V, Mavroudis D, Perraki M, Papadopoulos S, Apostolaki S, Stathopoulos E, Stathopoulou A, Lianidou E, Georgoulias V. Trastuzumab administration can effectively target chemotherapy-resistant cytokeratin-19 messenger RNA-positive tumor cells in the peripheral blood and bone marrow of patients with breast cancer. Clin Cancer Res. 2004;10(24):8185\u201394.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"993_CR7","first-page":"2073","volume":"8","author":"T Fehm","year":"2002","unstructured":"Fehm T, Sagalowsky A, Clifford E, Beitsch P, Saboorian H, Euhus D, Meng S, Morrison L, Tucker T, Lane N, et al. Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant. Clin Cancer Res. 2002;8(7):2073\u201384.","journal-title":"Clin Cancer Res"},{"issue":"8","key":"993_CR8","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/nm.3600","volume":"20","author":"CL Hodgkinson","year":"2014","unstructured":"Hodgkinson CL, Morrow CJ, Li Y, Metcalf RL, Rothwell DG, Trapani F, Polanski R, Burt DJ, Simpson KL, Morris K, et al. Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer. Nat Med. 2014;20(8):897\u2013903.","journal-title":"Nat Med"},{"issue":"24","key":"993_CR9","doi-asserted-by":"publisher","first-page":"8152","DOI":"10.1158\/1078-0432.CCR-04-1110","volume":"10","author":"S Meng","year":"2004","unstructured":"Meng S, Tripathy D, Frenkel EP, Shete S, Naftalis EZ, Huth JF, Beitsch PD, Leitch M, Hoover S, Euhus D, et al. Circulating tumor cells in patients with breast cancer dormancy. Clin Cancer Res. 2004;10(24):8152\u201362.","journal-title":"Clin Cancer Res"},{"issue":"9","key":"993_CR10","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1158\/1535-7163.MCT-12-1167","volume":"12","author":"G Kallergi","year":"2013","unstructured":"Kallergi G, Konstantinidis G, Markomanolaki H, Papadaki MA, Mavroudis D, Stournaras C, Georgoulias V, Agelaki S. Apoptotic circulating tumor cells in early and metastatic breast cancer patients. Mol Cancer Ther. 2013;12(9):1886\u201395.","journal-title":"Mol Cancer Ther"},{"issue":"6","key":"993_CR11","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1186\/s13058-014-0485-8","volume":"16","author":"M Spiliotaki","year":"2014","unstructured":"Spiliotaki M, Mavroudis D, Kapranou K, Markomanolaki H, Kallergi G, Koinis F, Kalbakis K, Georgoulias V, Agelaki S. Evaluation of proliferation and apoptosis markers in circulating tumor cells of women with early breast cancer who are candidates for tumor dormancy. Breast Cancer Res. 2014;16(6):485.","journal-title":"Breast Cancer Res"},{"issue":"9334","key":"993_CR12","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S0140-6736(02)09838-0","volume":"360","author":"CA Klein","year":"2002","unstructured":"Klein CA, Blankenstein TJ, Schmidt-Kittler O, Petronio M, Polzer B, Stoecklein NH, Riethmuller G. Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer. Lancet. 2002;360(9334):683\u20139.","journal-title":"Lancet"},{"issue":"1\u20132","key":"993_CR13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2119\/2006-00083.Kallergi","volume":"13","author":"G Kallergi","year":"2007","unstructured":"Kallergi G, Mavroudis D, Georgoulias V, Stournaras C. Phosphorylation of FAK, PI-3K, and impaired actin organization in CK-positive micrometastatic breast cancer cells. Mol Med. 2007;13(1\u20132):79\u201388.","journal-title":"Mol Med"},{"issue":"5","key":"993_CR14","doi-asserted-by":"publisher","first-page":"R80","DOI":"10.1186\/bcr2149","volume":"10","author":"G Kallergi","year":"2008","unstructured":"Kallergi G, Agelaki S, Kalykaki A, Stournaras C, Mavroudis D, Georgoulias V. Phosphorylated EGFR and PI3K\/Akt signaling kinases are expressed in circulating tumor cells of breast cancer patients. Breast Cancer Res. 2008;10(5):R80.","journal-title":"Breast Cancer Res"},{"issue":"3","key":"993_CR15","doi-asserted-by":"publisher","first-page":"5309","DOI":"10.18632\/oncotarget.14144","volume":"8","author":"S Agelaki","year":"2017","unstructured":"Agelaki S, Dragolia M, Markonanolaki H, Alkahtani S, Stournaras C, Georgoulias V, Kallergi G. Phenotypic characterization of circulating tumor cells in triple negative breast cancer patients. Oncotarget. 2017;8(3):5309\u201322.","journal-title":"Oncotarget"},{"key":"993_CR16","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s13058-015-0624-x","volume":"17","author":"G Kallergi","year":"2015","unstructured":"Kallergi G, Agelaki S, Papadaki MA, Nasias D, Matikas A, Mavroudis D, Georgoulias V. Expression of truncated human epidermal growth factor receptor 2 on circulating tumor cells of breast cancer patients. Breast Cancer Res. 2015;17:113.","journal-title":"Breast Cancer Res"},{"issue":"4","key":"993_CR17","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s00280-014-2387-y","volume":"73","author":"A Kalykaki","year":"2014","unstructured":"Kalykaki A, Agelaki S, Kallergi G, Xyrafas A, Mavroudis D, Georgoulias V. Elimination of EGFR-expressing circulating tumor cells in patients with metastatic breast cancer treated with gefitinib. Cancer Chemother Pharmacol. 2014;73(4):685\u201393.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"7","key":"993_CR18","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1093\/annonc\/mds020","volume":"23","author":"V Georgoulias","year":"2012","unstructured":"Georgoulias V, Bozionelou V, Agelaki S, Perraki M, Apostolaki S, Kallergi G, Kalbakis K, Xyrafas A, Mavroudis D. Trastuzumab decreases the incidence of clinical relapses in patients with early breast cancer presenting chemotherapy-resistant CK-19 mRNA-positive circulating tumor cells: results of a randomized phase II study. Ann Oncol. 2012;23(7):1744\u201350.","journal-title":"Ann Oncol"},{"issue":"14","key":"993_CR19","doi-asserted-by":"publisher","first-page":"5678","DOI":"10.1158\/0008-5472.CAN-07-6589","volume":"68","author":"RA Whipple","year":"2008","unstructured":"Whipple RA, Balzer EM, Cho EH, Matrone MA, Yoon JR, Martin SS. Vimentin filaments support extension of tubulin-based microtentacles in detached breast tumor cells. Cancer Res. 2008;68(14):5678\u201388.","journal-title":"Cancer Res"},{"issue":"20","key":"993_CR20","doi-asserted-by":"publisher","first-page":"8127","DOI":"10.1158\/0008-5472.CAN-09-4613","volume":"70","author":"RA Whipple","year":"2010","unstructured":"Whipple RA, Matrone MA, Cho EH, Balzer EM, Vitolo MI, Yoon JR, Ioffe OB, Tuttle KC, Yang J, Martin SS. Epithelial-to-mesenchymal transition promotes tubulin detyrosination and microtentacles that enhance endothelial engagement. Cancer Res. 2010;70(20):8127\u201337.","journal-title":"Cancer Res"},{"issue":"48","key":"993_CR21","doi-asserted-by":"publisher","first-page":"6402","DOI":"10.1038\/onc.2010.360","volume":"29","author":"EM Balzer","year":"2010","unstructured":"Balzer EM, Whipple RA, Thompson K, Boggs AE, Slovic J, Cho EH, Matrone MA, Yoneda T, Mueller SC, Martin SS. C-Src differentially regulates the functions of microtentacles and invadopodia. Oncogene. 2010;29(48):6402\u20138.","journal-title":"Oncogene"},{"issue":"4","key":"993_CR22","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1158\/0008-5472.CAN-13-1778","volume":"74","author":"MS Charpentier","year":"2014","unstructured":"Charpentier MS, Whipple RA, Vitolo MI, Boggs AE, Slovic J, Thompson KN, Bhandary L, Martin SS. Curcumin targets breast cancer stem-like cells with microtentacles that persist in mammospheres and promote reattachment. Cancer Res. 2014;74(4):1250\u201360.","journal-title":"Cancer Res"},{"issue":"22","key":"993_CR23","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1038\/onc.2010.68","volume":"29","author":"MA Matrone","year":"2010","unstructured":"Matrone MA, Whipple RA, Thompson K, Cho EH, Vitolo MI, Balzer EM, Yoon JR, Ioffe OB, Tuttle KC, Tan M, et al. Metastatic breast tumors express increased tau, which promotes microtentacle formation and the reattachment of detached breast tumor cells. Oncogene. 2010;29(22):3217\u201327.","journal-title":"Oncogene"},{"issue":"18","key":"993_CR24","doi-asserted-by":"publisher","first-page":"8558","DOI":"10.18632\/oncotarget.2338","volume":"5","author":"NA Perry","year":"2014","unstructured":"Perry NA, Vitolo MI, Martin SS, Kontrogianni-Konstantopoulos A. Loss of the obscurin-RhoGEF downregulates RhoA signaling and increases microtentacle formation and attachment of breast epithelial cells. Oncotarget. 2014;5(18):8558\u201368.","journal-title":"Oncotarget"},{"issue":"13","key":"993_CR25","first-page":"5024","volume":"61","author":"A Mialhe","year":"2001","unstructured":"Mialhe A, Lafanechere L, Treilleux I, Peloux N, Dumontet C, Bremond A, Panh MH, Payan R, Wehland J, Margolis RL, et al. Tubulin detyrosination is a frequent occurrence in breast cancers of poor prognosis. Cancer Res. 2001;61(13):5024\u20137.","journal-title":"Cancer Res"},{"key":"993_CR26","first-page":"601810","volume":"2012","author":"K Hekimian","year":"2012","unstructured":"Hekimian K, Meisezahl S, Trompelt K, Rabenstein C, Pachmann K. Epithelial cell dissemination and readhesion: analysis of factors contributing to metastasis formation in breast cancer. ISRN Oncol. 2012;2012:601810.","journal-title":"ISRN Oncol"},{"issue":"397","key":"993_CR27","doi-asserted-by":"publisher","first-page":"eaan0026","DOI":"10.1126\/scitranslmed.aan0026","volume":"9","author":"GS Karagiannis","year":"2017","unstructured":"Karagiannis GS, Pastoriza JM, Wang Y, Harney AS, Entenberg D, Pignatelli J, Sharma VP, Xue EA, Cheng E, D\u2019Alfonso TM, et al. Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediated mechanism. Sci Transl Med. 2017;9(397):eaan0026.","journal-title":"Sci Transl Med"},{"issue":"1","key":"993_CR28","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10549-009-0457-3","volume":"121","author":"EM Balzer","year":"2010","unstructured":"Balzer EM, Whipple RA, Cho EH, Matrone MA, Martin SS. Antimitotic chemotherapeutics promote adhesive responses in detached and circulating tumor cells. Breast Cancer Res Treat. 2010;121(1):65\u201378.","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"993_CR29","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s10549-010-1239-7","volume":"129","author":"JR Yoon","year":"2011","unstructured":"Yoon JR, Whipple RA, Balzer EM, Cho EH, Matrone MA, Peckham M, Martin SS. Local anesthetics inhibit kinesin motility and microtentacle protrusions in human epithelial and breast tumor cells. Breast Cancer Res Treat. 2011;129(3):691\u2013701.","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"993_CR30","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1056\/NEJMoa040766","volume":"351","author":"M Cristofanilli","year":"2004","unstructured":"Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LW, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med. 2004;351(8):781\u201391.","journal-title":"N Engl J Med"},{"issue":"3\u20134","key":"993_CR31","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1159\/000452556","volume":"40","author":"G Kallergi","year":"2016","unstructured":"Kallergi G, Politaki E, Alkahtani S, Stournaras C, Georgoulias V. Evaluation of isolation methods for circulating tumor cells (CTCs). Cell Physiol Biochem. 2016;40(3\u20134):411\u20139.","journal-title":"Cell Physiol Biochem"},{"issue":"2","key":"993_CR32","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228\u201347.","journal-title":"Eur J Cancer"},{"issue":"7","key":"993_CR33","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1200\/JCO.2005.08.140","volume":"23","author":"M Cristofanilli","year":"2005","unstructured":"Cristofanilli M, Hayes DF, Budd GT, Ellis MJ, Stopeck A, Reuben JM, Doyle GV, Matera J, Allard WJ, Miller MC, et al. Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol. 2005;23(7):1420\u201330.","journal-title":"J Clin Oncol"},{"issue":"16","key":"993_CR34","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1200\/JCO.2002.08.135","volume":"20","author":"A Stathopoulou","year":"2002","unstructured":"Stathopoulou A, Vlachonikolis I, Mavroudis D, Perraki M, Kouroussis C, Apostolaki S, Malamos N, Kakolyris S, Kotsakis A, Xenidis N, et al. Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance. J Clin Oncol. 2002;20(16):3404\u201312.","journal-title":"J Clin Oncol"},{"issue":"23","key":"993_CR35","doi-asserted-by":"publisher","first-page":"3756","DOI":"10.1200\/JCO.2005.04.5948","volume":"24","author":"N Xenidis","year":"2006","unstructured":"Xenidis N, Perraki M, Kafousi M, Apostolaki S, Bolonaki I, Stathopoulou A, Kalbakis K, Androulakis N, Kouroussis C, Pallis T, et al. Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node-negative breast cancer patients. J Clin Oncol. 2006;24(23):3756\u201362.","journal-title":"J Clin Oncol"},{"issue":"9","key":"993_CR36","doi-asserted-by":"publisher","first-page":"3514","DOI":"10.1073\/pnas.1320198111","volume":"111","author":"DL Adams","year":"2014","unstructured":"Adams DL, Martin SS, Alpaugh RK, Charpentier M, Tsai S, Bergan RC, Ogden IM, Catalona W, Chumsri S, Tang CM, et al. Circulating giant macrophages as a potential biomarker of solid tumors. Proc Natl Acad Sci U S A. 2014;111(9):3514\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"993_CR37","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1158\/1055-9965.EPI-15-1221","volume":"25","author":"DL Adams","year":"2016","unstructured":"Adams DL, Adams DK, Alpaugh RK, Cristofanilli M, Martin SS, Chumsri S, Tang CM, Marks JR. Circulating cancer-associated macrophage-like cells differentiate malignant breast Cancer and benign breast conditions. Cancer Epidemiol Biomarkers Prev. 2016;25(7):1037\u201342.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"993_CR38","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1158\/0008-5472.CAN-13-3563","volume":"75","author":"AE Boggs","year":"2015","unstructured":"Boggs AE, Vitolo MI, Whipple RA, Charpentier MS, Goloubeva OG, Ioffe OB, Tuttle KC, Slovic J, Lu Y, Mills GB, et al. Alpha-tubulin acetylation elevated in metastatic and basal-like breast cancer cells promotes microtentacle formation, adhesion, and invasive migration. Cancer Res. 2015;75(1):203\u201315.","journal-title":"Cancer Res"},{"issue":"3","key":"993_CR39","doi-asserted-by":"publisher","first-page":"387","DOI":"10.4149\/gpb_2016009","volume":"35","author":"D Flodrova","year":"2016","unstructured":"Flodrova D, Toporova L, Macejova D, Lastovickova M, Brtko J, Bobalova J. A comparative study of protein patterns of human estrogen receptor positive (MCF-7) and negative (MDA-MB-231) breast cancer cell lines. Gen Physiol Biophys. 2016;35(3):387\u201392.","journal-title":"Gen Physiol Biophys"},{"issue":"5","key":"993_CR40","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.cell.2014.07.013","volume":"158","author":"N Aceto","year":"2014","unstructured":"Aceto N, Bardia A, Miyamoto DT, Donaldson MC, Wittner BS, Spencer JA, Yu M, Pely A, Engstrom A, Zhu H, et al. Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell. 2014;158(5):1110\u201322.","journal-title":"Cell"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-018-0993-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13058-018-0993-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-018-0993-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T19:08:58Z","timestamp":1562267338000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/s13058-018-0993-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,5]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["993"],"URL":"https:\/\/doi.org\/10.1186\/s13058-018-0993-z","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,5]]},"assertion":[{"value":"25 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The protocol was approved by the ethics and scientific committees of our institution (D. Georgopoulos, I. Galanakis, I. Papadakis, H. Athanasakis, E. Kabitakis, M. Venihaki, A. Andreou, M. Grammatopouloou, M. Tabakaki), and all patients and healthy blood donors gave their informed consent to participate in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Our study does not contain any individual person\u2019s data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"67"}}